Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Monopar Therapeutics Inc. | StockGist | StockGist

Companies
MNPR
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings MNPRSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Monopar Therapeutics Inc.

Filed Feb 12, 2025

Accepted Feb 11, 2025, 7:00 PM ET

CIK 0001645469

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

6,076,451

Reporting Person

Monopar Therapeutics

Person Type

IA

CUSIP: 61023L207

Amendment History

7 filings

SCHEDULE 13G
Original
Viewing
Feb 12, 20250000902664-25-000879
SCHEDULE 13G/A
Amendment 1
Jan 8, 20250001274173-25-000003
SCHEDULE 13G/A
Amendment 2
Feb 14, 20250001415889-25-004259
SCHEDULE 13G/A
Amendment 3
Feb 14, 20250001214659-25-002804
SCHEDULE 13G/A
Amendment 4
May 14, 20250001274173-25-000127
SCHEDULE 13G/A
Amendment 5
Aug 14, 20250001274173-25-000207
SCHEDULE 13G/A
Amendment 6
Latest
Feb 17, 20260001346824-26-000051

Key Facts

Shares Owned

6,076,451

Recent Filings

Monopar Therapeutics Inc.4 days ago

Monopar Therapeutics Inc.1 weeks ago

Monopar Therapeutics Inc.1 months ago

Monopar Therapeutics Inc.1 months ago

Monopar Therapeutics Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice